Skip to main content
Nyxoah SA logo

Nyxoah SA — Investor Relations & Filings

Ticker · NYXH ISIN · BE0974358906 LEI · 5493002O1ESKZ18OXR80 BR Manufacturing
Open in API
Filings indexed 595 across all filing types
Latest filing 2026-05-20 Share Issue/Capital Cha…
Country BE Belgium
Listing BR NYXH

About Nyxoah SA

https://www.nyxoah.com/

Nyxoah SA is a medical technology company focused on the development and commercialization of solutions for Obstructive Sleep Apnea (OSA). The company's lead product is the Genio® system, a hypoglossal neurostimulation (HNS) therapy designed for patients with moderate to severe OSA. The system features a patient-centered, leadless, and battery-free implantable stimulator. It functions by providing bilateral stimulation to the hypoglossal nerve, which controls tongue muscles, to maintain an open airway during sleep.

Recent filings

Filing Released Lang Actions
2026 05 20 - Press release - Number of shares (ENG).pdf
Share Issue/Capital Change Classification · 85% confidence The document is a regulated information release by the company updating the share capital and total voting rights following the issuance of 1,031,323 new shares as part of a convertible bond transaction. It specifically announces a change in capital structure (new shares issued) and updated voting rights. This fits the definition of a Share Issue/Capital Change announcement (SHA).
2026-05-20 English
2026 05 20 - Press release - Number of shares (FR).pdf
Share Issue/Capital Change Classification · 82% confidence The document is a regulated information announcement disclosing the issuance of 1,031,323 new shares and the resulting update of the company’s share capital, total number of shares, and voting rights. This is a straightforward announcement of a share issue and capital change rather than a full report or proxy statement. According to the filing definitions, this falls under “Share Issue/Capital Change” (SHA).
2026-05-20 French
Contribution in kind_May 2026_Special board report_ENG.pdf
Share Issue/Capital Change Classification · 87% confidence The document is a detailed special report prepared by the Board of Directors pursuant to Belgian company law in connection with a capital increase by way of contribution in kind and the issuance of new shares. It contains the background, valuation, consideration, and mechanics of the share issue. This directly corresponds to an announcement of a share issue/capital change. Therefore, it should be classified under Share Issue/Capital Change (SHA).
2026-05-20 English
Contribution in kind_May 2026_Special board report_FR.pdf
Share Issue/Capital Change Classification · 87% confidence The document is a detailed “Rapport spécial du Conseil d’Administration” prepared under Belgian company law describing and justifying a proposed capital increase by way of contribution in kind and the terms of issuance of new shares. It is not merely an announcement of publication nor an MD&A or earnings release, but a legal board report specifically concerning a share issuance/capital change. This best matches the “Share Issue/Capital Change” category (SHA).
2026-05-20 French
6-K - Nyxoah SA (0001857190) (Filer)
Regulatory Filings
2026-05-12 English
11 - Statutory annual accounts - ENG.pdf
Regulatory Filings
2026-05-08 English

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.